- AuthorisedTherapeutic exploratory (Phase II)
Efficacy and safety of a combined therapy with Alpha-Lipoic Acid and Benfotiamine in the symptomatic treatment of diabetic sensorimotor polyneuropathy - a prospective, randomized, controlled, parallel group, double-blind, double-dummy 3-arm trial
This study is testing if a combination of two medicines, alpha-lipoic acid and benfotiamine, can help people with nerve damage from diabetes. Researchers want to see if this treatment improves symptoms and is safe to use.
For: Diabetic sensorimotor polyneuropathy (DSPN)Hungary - Ongoing, recruitingPhase II and Phase III (Integrated)
Long-term aspirin therapy as a predictor of decreased susceptibility to SARSCoV-2 infection in aspirin-exacerbated respiratory disease
This study looks at whether a special treatment for people with Aspirin-Exacerbated Respiratory Disease (AERD) can reduce their risk of getting COVID-19. They're testing if taking a particular type of aspirin long-term after initial desensitisation changes how certain genes work and makes you less likely to catch the virus.
For: aspirin-exacerbated respiratory diseasePoland - Ongoing, recruitingHuman Pharmacology (Phase I)- Other
A PHASE 1, OPENLABEL, SINGLECENTER STUDY TO EVALUATE DRUGDRUG INTERACTIONS WITH GEMFIBROZIL, ITRACONAZOLE, AND CARBAMAZEPINE AND THE FOOD-EFFECT ON ORAL LERIGLITAZONE IN MALE HEALTHY SUBJECTS
This study is looking at how a new drug, leriglitazone, behaves in the body of healthy men. It checks if other common medicines or food affect how leriglitazone works. This helps us understand its safety and effectiveness for conditions like Adrenoleukodystrophy.
For: AdrenoleukodystrophyPoland